A panel of experts advising the U.S. Food and Drug Administration (FDA) voted against adopting MDMA as a treatment for post-traumatic stress disorder (PTSD) on Tuesday. Members of the FDA’s Psychopharmacologic Drugs Advisory Committee said that they did not feel there is sufficient evidence to show that the drug is effective in a 9-2 vote. In a 10-1 vote, experts overwhelmingly said that the benefits of MDMA, commonly known as ecstasy or molly, do not outweigh the risks. [time-brightcove not-tgx=”true”] The panel was tasked with evaluating a proposed treatment developed by Lykos Therapeutics, which involves taking prescribed doses of MDMA under the supervision of clinicians pr
Hence then, the article about fda advisors recommend against using mdma for ptsd treatment was published today ( ) and is available onTime ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA Advisors Recommend Against Using MDMA for PTSD Treatment )